: a coding sequence variant in the cancer gene, a total copy number = 0 (homozygous deletion) or ≥ 8 (amplification), we grouped the unassayed cell lines based on their EGFR mutation profiles and found that the EGFR mutated cell lines were significantly more sensitive to lapatinib. The gene discussed is EGFR; the disease is cancer.